.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203137

« Back to Dashboard
NDA 203137 describes VIZAMYL, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the VIZAMYL profile page.

The generic ingredient in VIZAMYL is flutemetamol f-18. One supplier is listed for this compound. Additional details are available on the flutemetamol f-18 profile page.

Summary for NDA: 203137

Tradename:
VIZAMYL
Applicant:
Ge Healthcare
Ingredient:
flutemetamol f-18
Patents:5

Pharmacology for NDA: 203137

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 203137

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIZAMYL
flutemetamol f-18
INJECTABLE;INTRAVENOUS 203137 NDA Medi-Physics Inc. 17156-067 17156-067-10 1 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-10) > 10 mL in 1 VIAL, MULTI-DOSE
VIZAMYL
flutemetamol f-18
INJECTABLE;INTRAVENOUS 203137 NDA Medi-Physics Inc. 17156-067 17156-067-30 1 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) > 30 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength40.5mCi/10ML (4.05mCi/ML)
Approval Date:Oct 25, 2013TE:RLD:Yes
Patent:8,236,282Patent Expiration:May 21, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:8,916,131Patent Expiration:Sep 16, 2028Product Flag?YSubstance Flag?Delist Request?
Patent:7,270,800Patent Expiration:Apr 14, 2027Product Flag?YSubstance Flag?YDelist Request?
Patented Use:DIAGNOSTIC RADIOIMAGING


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc